During the past decade, Wilmington Medical Research conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wilmington Medical Research" #1 sponsor was "Bristol-Myers Squibb" with 3 trials, followed by "Merz Pharmaceuticals GmbH" with 2 trials sponsored, "Apnex Medical, Inc." with 1 trials sponsored, "Bial - Portela C S.A." with 1 trials sponsored and "Galderma R&D" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wilmington Medical Research" #1 collaborator was "Pfizer" with 3 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Sunovion" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Wilmington Medical Research" are "Subjective Tinnitus" (2 trials), "Venous Thrombosis" (2 trials), "Acute Coronary Syndrome" (1 trials), "Meniere's Disease" (1 trials) and "Obstructive Sleep Apnea" (1 trials). Many other conditions were trialed in "Wilmington Medical Research" in a lesser frequency.

Most popular intervention types in "Wilmington Medical Research" are "Drug" (9 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Apixaban" (2 trials), "Neramexane mesylate" (2 trials), "1200 mg QD Eslicarbazepine acetate" (1 trials) and "800 mg QD Eslicarbazepine acetate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wilmington Medical Research" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Wilmington Medical Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Wilmington Medical Research, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Wilmington Medical Research, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".